Assessment of oxidative stress markers and prostaglandins after chronic training of triathletes

Prostaglandins and Other Lipid Mediators

Volumn 99, Issue 3-4, 2012, Pages 79-86

  Medina, Sonia ^a   Domínguez Perles, Raul ^a   Cejuela Anta, Roberto ^b   Villaño, Débora ^a   Martínez Sanz, José M ^b   Gil, Pilar ^c   García Viguera, Cristina ^a   Ferreres, Federico ^a   Gil, José I ^d   Gil Izquierdo, Angel ^a  

^a RESEARCH GROUP ON QUALITY   (Spain)

^b UNIVERSITY OF ALICANTE   (Spain)

^c University General Hospital of Alicante   (Spain)

^d HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

Enzymatic hydrolysis; Isoprostane; Oxidative stress; Prostaglandin; Thromboxane; Triathletes

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; 8 ISOPROSTAGLANDIN F2 ALPHA; BIOLOGICAL MARKER; GLUCURONIC ACID; ISOPROSTANE DERIVATIVE; LIPID; PROSTAGLANDIN; PROSTAGLANDIN F2 ALPHA;

ADULT; ARTICLE; ATHLETE; CHRONIC TRAINING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXERCISE; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; LIPID PEROXIDATION; MALE; MASS SPECTROMETRY; METABOLITE; NORMAL HUMAN; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PROSTAGLANDIN METABOLISM; QUANTITATIVE ANALYSIS; THROMBOCYTE AGGREGATION; TRAINING; TRIATHLETE; TRIATHLON; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; VASODILATATION;

ADOLESCENT; ADULT; ATHLETES; ATHLETIC PERFORMANCE; BIOLOGICAL MARKERS; BLOOD PLATELETS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXERCISE; FEMALE; HUMANS; ISOPROSTANES; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PLATELET AGGREGATION; PROSTAGLANDINS; TANDEM MASS SPECTROMETRY; VASODILATION;

EID: 84869087761     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2012.07.002     Document Type: Article

References (53)

1. C.D. Funk Prostaglandins and leukotrienes: advances in eicosanoid biology Science 294 5548 2001 1871 1875 (Pubitemid 33101574)
2. S. Bergström, H. Danielsson, and B. Samuelsson The enzymatic formation of prostaglandin E2 from arachidonic acid Biochim Biophys Acta 90 1964 207 210
3. 1α by UFLC-MS/MS before and after exercise Prostaglandins Other Lipid Mediat 93 1-2 2010 8 13
4. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism Proc Natl Acad Sci USA 87 23 1990 9383 9387 (Pubitemid 120030630)
5. J.D. Morrow, T.A. Minton, and C.R. Mukundan Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes J Biol Chem 269 6 1994 4317 4326
6. J.L. Cracowski, F. Stanke-Labesque, C. Souvignet, and G. Bessard Isoprostanes: new markers for oxidative stress in human disease Isoprostanes: Nouveaux marqueurs du stress oxydant en pathologie humaine Presse Méd 29 11 2000 604 610 (Pubitemid 30187076)
7. 2-isoprostanes in patients with severe heart failure [2] Heart 84 4 2000 439 440
8. L.J. Roberts Ii, and J.D. Morrow The generation and actions of isoprostanes Biochim Biophys Acta: Lipids Lipid Metab 1345 2 1997 121 135 (Pubitemid 27138414)
9. B. Halliwell Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species: measurement, mechanism and the effects of nutrition Mutat Res: Genet Toxicol Environ Mutagen 443 1-2 1999 37 52 (Pubitemid 29327265)
10. D. Milatovic, T.J. Montine, and M. Aschner Methods Mol Biol 758 2011 195 204
11. K.H. Schmitz, M. Warren, A.G. Rundle, N.I. Williams, M.D. Gross, and M.S. Kurzer Exercise effect on oxidative stress is independent of change in estrogen metabolism Cancer Epidemiol Biomarkers Prev 17 1 2008 220 223 (Pubitemid 351196294)
12. 2-isoprostanes as novel biomarkers for type 2 diabetes: a review J Clin Biochem Nutr 45 1 2009 1 8
13. J.M. Little, M. Kurkela, and J. Sonka Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases J Lipid Res 45 2004 1694 1703 (Pubitemid 39296209)
14. J.D. Morrow, W.E. Zackert, and J.P. Yang Quantification of the major urinary metabolite of 15-F(2T)-isoprostane (8-iso-PGF(2 I ̂ )) by a stable isotope dilution mass spectrometric assay Anal Biochem 269 2 1999 326 331 (Pubitemid 29201031)
15. 2-isoprostanes in urine by online solid phase extraction coupled to liquid chromatography with tandem mass spectrometry J Agric Food Chem 58 11 2010 6614 6620
16. M. Comporti, C. Signorini, B. Arezzini, D. Vecchio, B. Monaco, and C. Gardi Isoprostanes and hepatic fibrosis Mol Aspects Med 29 1-2 2008 43 49 (Pubitemid 351312219)
17. T. Ide, H. Tsutsui, and N. Ohashi Greater oxidative stress in healthy young men compared with premenopausal women Arterioscler Thromb Vasc Biol 22 3 2002 438 442 (Pubitemid 34218751)
18. B. Halliwell Superoxide, iron, vascular endothelium and reperfusion injury Free Radic Res Commun 5 6 1989 315 318 (Pubitemid 19096102)
19. M.G. Nikolaidis, A.Z. Jamurtas, V. Paschalis, I.G. Fatouros, Y. Koutedakis, and D. Kouretas The effect of muscle-damaging exercise on blood and skeletal muscle oxidative stress: magnitude and time-course considerations Sports Med 38 7 2008 579 606 (Pubitemid 351861946)
20. S. Medina, R. Dominguez-Perles, and J.I. Gil UPLC-TripleQuad-MS/MS method for 13 prostanoid analyses in human urine and quantitative 24 h values in healthy volunteers in a controlled constant diet Rapid Commun Mass Spectrom 26 2012 1249 1257
21. L. Speid 1st ed. Clinical trials: what patients and volunteers need to know vol. 1 2010 Oxford University Press, Inc. USA
22. M.D. Cabañas Armesilla E.R.F. Compendio de cineantropometria 1st ed. 2009 CTO Editorial Madrid
23. International Society of Advancement of Kinanthropometry (ISAK: http://www.isakonline.com).
24. C.A.M. Alvero Cruz Jr., A. Herrero de Lucas, and L. Martínez Riaza Protocolo de valoración de la composición corporal para el reconocimiento médico-deportivo. documento de. Consenso del grupo español de cineantropometría de la federación española de medicina del deporte Arch Med Deporte 27 139 2010 330 344
25. R.T. Withers, N.P. Craig, P.C. Bourdon, and K.I. Norton Relative body fat and anthropometric prediction of body density of male athletes Eur J Appl Physiol 56 1987 191 200 (Pubitemid 17028483)
26. R.T. Withers, N.O. Whittingham, K.I. Norton, J. La Forgia, M.W. Ellis, and A. Crockett Relative body fat and anthropometric prediction of body density of female athletes Eur J Appl Physiol 56 1987 169 180 (Pubitemid 17028481)
27. R.C. Lee, Z. Wang, M. Heo, R. Ross, I. Janssen, and S. Heymsfield Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models Am J Clin Nutr 72 2000 796 803
28. J. Borresen, and M.I. Lambert The quantification of training load, the training response and the effect on performance Sports Med 39 9 2009 779 795
29. E.W. Banister, and T.W. Calvert Planning for future performance: implications for long term training Can J Appl Sport Sci 5 1980 170 176
30. A. Lucia, J. Esteve-Lanao, and J. Oliván Physiological characteristics of the best Eritrean runners - exceptional running economy Appl Physiol Nutr Metab 31 2006 1 11
31. R. Cejuela Anta, and J. Esteve-Lanao Training load quantification in triathletes J Hum Sport Exerc 6 2 2011 218 232
32. J.A. Rodríguez-Marroyo, C. García López, F. Avila, A. Jiménez, A. Córdova, and J.G. Villa-Vicente Intensity of exercise according to topography in professional cyclists Med Sci Sports Exerc 35 7 2003 1209 1215 (Pubitemid 36807985)
33. 2-isoprostanes in human urine are excreted as glucuronide conjugates Anal Biochem 403 1-2 2010 126 128
34. M. Silberberg, A. Gil-Izquierdo, L. Combaret, C. Remesy, A. Scalbert, and C. Morand Flavanone metabolism in healthy and tumor-bearing rats Biomed Pharmacother 60 9 2006 529 535 (Pubitemid 44635084)
35. V. Habauzit, I.L. Nielsen, and A. Gil-Izquierdo Increased bioavailability of hesperetin-7-glucoside compared with hesperidin results in more efficient prevention of bone loss in adult ovariectomised rats Br J Nutr 102 7 2009 976 984
36. V. Ferchaud, P. Courcoux, B. Le Bizec, F. Monteau, and F. Andre Enzymatic hydrolysis of conjugated steroid metabolites: search for optimum conditions using response surface methodology Analyst 125 2000 2255 2259 (Pubitemid 32015659)
37. K. Moore Isoprostanes and the liver Chem Phys Lipids 128 1-2 2004 125 133 (Pubitemid 38167382)
38. 2-isoprostanes as markers of in vivo lipid peroxidation: a comparison of enzyme immunoassays with gas chromatography-mass spectrometry in domestic animal species J Vet Diagn Invest 22 2010 200 209
39. D.M. Callewaert, and C. Sloan Enzyme immunoassay of isoprostanes Methods Mol Biol 610 2010 435 449
40. P.T. Campbell, M.D. Gross, and J.D. Potter Effect of exercise on oxidative stress: a 12-month randomized, controlled trial Med Sci Sports Exerc 42 8 2010 1448 1453
41. M. Karamouzis, E. Karamouzis, and E. Vamvakoudis The response of muscle interstitial prostaglandin E2 (PGE2), prostacyclin I2 (PGI2) and thromboxane A2 (TXA2) levels during incremental dynamic exercise in humans determined by in vivo microdialysis Prostaglandins Leukot Essent Fatty Acids 64 2001 259 263 (Pubitemid 32620000)
42. A. Stergioulas, A. Tripolitsioti, and A. Nicolau The effect of a classic spartathlon race on lipids and prostanoids in endurance male athletes, Pakistan J Biol Sci 22 2008 2139 2143 (Pubitemid 352845735)
43. H. Ronni-Sivula, H. Malm, O. Ylikorkala, and L. Viinikka Marathon run stimulates more prostacyclin than thromboxane synthesis and differently in men and women Prostaglandins 46 1 1993 75 79 (Pubitemid 23236469)
44. A. Wennmalm, and G.A. Fitzgerald Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humans Am J Physiol 255 1 Pt 2 1988 H15 H18
45. R. Jackson, C. Ramos, C. Gupta, and O. Gomez-Marin Exercise decreases plasma antioxidant capacity and increases urinary isoprostanes of IPF patients Respir Med 104 12 2010 1919 1928
46. M.C. Devries, M.J. Hamadeh, A.W. Glover, S. Raha, I.A. Samjoo, and M.A. Tarnopolsky Endurance training without weight loss lowers systemic, but not muscle, oxidative stress with no effect on inflammation in lean and obese women Free Radic Biol Med 45 4 2008 503 511
47. L.J. Roberts Ii, and J.D. Morrow Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation Cell Mol Life Sci 59 5 2002 808 820 (Pubitemid 34628242)
48. B. Rosenkranz, C. Fischer, I. Reimann, K.E. Weimer, G. Beck, and J.C. Frölich Identification of the major metabolite of prostacyclin and 6-ketoprostaglandin F1 alpha in man Biochim Biophys Acta 619 2 1980 207 213 (Pubitemid 10022690)
49. T. Hishinuma, Y. Koseki, Y. Murai, T. Yamazaki, K. Suzuki, and M. Mizugaki Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic Prostaglandins Other Lipid Mediat 58 5-6 1999 263 271
50. G. Rasmanis, O. Vesterqvist, K. Gréen, and P. Henriksson Implications of the prognostic importance of exercise-induced thromboxane formation in survivors of an acute myocardial infarction Prostaglandins 49 4 1995 247 253
51. G. Rasmanis, O. Vesterqvist, K. Gréen, O. Edhag, and P. Henriksson Prostacyclin production in myocardial infarction in the acute phase and during follow-up J Intern Med 229 2 1991 135 141
52. A. Wennmalm, J. Nowak, and T. Bjurö Excretion of thromboxane A2 and prostacyclin metabolites before and after exercise testing in patients with and without signs of ischemic heart disease Circulation 82 5 1990 1737 1743 (Pubitemid 20367977)
53. A. Wennmalm, A. Edlund, B. Sevastik, and G.A. FitzGerald Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication Clin Physiol 8 3 1988 243 253